The effects of 1, 10, or 40 juglml of vanadium, given for six or seven months as sodium metavanadate in drinking water on cardiovascular and biochemical variables and the electrolyte metabolism of male Sprague-Dawley rats were investigated. At the end of the exposure period, all animals exposed to vanadate had increased systolic and diastolic blood pressure. This effect was not dose dependent and heart rate and cardiac inotropism were not affected. The role of defective renal function and electrolyte metabolism in such effects was supported, in the rats exposed to 10 and 40 ppm of vanadium, by the following changes: (a) decreased Na,+ K+-ATPase activity in the distal tubules of nephrons; (b) increased urinary excretion of potassium; (c) increase in plasma renin activity and urinary kallikrein, kininase I, and kininase II activities; (d) increased plasma aldosterone (only in the rats treated with 10 ppm of vanadium). The alterations in the rats exposed to 1 ppm of vanadium were: (a) reduced urinary calcium excretion; (b) reduced urinary kallikrein activity; (c) reduced plasma aldosterone. These results suggest that blood hypertension in rats exposed to vanadate depends on specific mechanisms of renal toxicity related to the levels of exposure.
dium, given for six or seven months as sodium metavanadate in drinking water on cardiovascular and biochemical variables and the electrolyte metabolism of male Sprague-Dawley rats were investigated. At the end of the exposure period, all animals exposed to vanadate had increased systolic and diastolic blood pressure. This effect was not dose dependent and heart rate and cardiac inotropism were not affected. The role of defective renal function and electrolyte metabolism in such effects was supported, in the rats exposed to 10 and 40 ppm of vanadium, by the following changes: (a) decreased Na,+ K+-ATPase activity in the distal tubules of nephrons; (b) increased urinary excretion of potassium; (c) increase in plasma renin activity and urinary kallikrein, kininase I, and kininase II activities; (d) increased plasma aldosterone (only in the rats treated with 10 ppm of vanadium). The alterations in the rats exposed to 1 ppm of vanadium were: (a) reduced urinary calcium excretion; (b) reduced urinary kallikrein activity; (c) reduced plasma aldosterone. These results suggest that blood hypertension in rats exposed to vanadate depends on specific mechanisms of renal toxicity related to the levels of exposure. 4 The concentrations of vanadium in the environment are increasing. Combustion of coal and oil in power plants for electric production mobilised about 10 000-20 000 tonnes of vanadium/year in the past decade.5 Environmental vanadium may affect the health of humans through digestion of contaminated food or retention of inhaled vanadium compounds. The inhalation of vanadium induced respiratory disorders in workers cleaning oil fired boilers or handling petroleum. 6 Within the cardiovascular system, exposure to vanadate induced the increase of both blood pressure and heart rate in SpragueDawley rats.7-9 In these animals, baroafferent sensitivity and vagal parasympathetic activity were reduced, whereas sympathetic tone and cardiovascular responsiveness of a,, PI, and /2 adrenergic receptors were augmented; the hypotensive and positive inotropic effects of bradykinin were also potentiated, indicating that vanadium affects the kallikrein-kinin system.89
In another study, sodium metavanadate, given by intravenous infusion to conscious dogs, increased systemic blood pressure, total peripheral resistance, pulmonary arterial pressure, and cardiac output, and suppressed plasma renin activity.'0
The purpose of our study was to investigate whether, in Sprague-Dawley rats, chronic exposure to doses of vanadium below those used previously,7-9 could modify cardiovascular homeostasis through effects on the kallikrein-kinin and renin-angiotensin systems.
Material and methods

FIRST EXPERIMENT
Eighteen male weaning Sprague-Dawley rats, randomly divided into three equal groups, were housed in stainless steel cages and kept on a standard laboratory diet. One group received 40 ,ug/ml of vanadium, and the second group 10 yug/ml of vanadium, as sodium metavanadate (NaVO,), in drinking water for 210 days. The third group served as a control. SECOND 
EXPERIMENT
Twelve male weaning Sprague-Dawley rats were randomly divided into two equal groups, housed in stainless steel cages, and kept on a standard laboratory diet. One group received 1 jug/ml of vanadium, as NaVO, in drinking Table 1 Mean (SEM) blood pressure, heart rate, and maximum rate of rise ofleft ventricular isovolumetnic pressure (dPIdt) in rats chronically exposed to different doses of vanadium (n = 6) At the end of both treatments all rats were placed in metabolism cages and 24 h urine samples were collected. All animals were then anaesthetised with a single intraperitoneal injection of thiopentone sodium (50 mg/kg body weight) to perform haemodynamic measurements. The trachea was cannulated to allow spontaneous breathing and polyethylene , catheters (containing sodium heparin, 100
United States pharmacopeia units/ml) were placed in the left femoral artery to record aortic blood pressure. After cardiovascular measurements, blood samples were collected from the carotid artery for the determination of plasma renin activity'3 and plasma aldosterone."4 Samples of several tissues were then excised for histopathological examination by light microscopy. The Na+, K+-ATPase activity was assayed by a histochemical method"5 in the kidneys of rats exposed to 40 ppm of vanadium. Samples of tissues were also excised for the determination of vanadium by neutron activation analysis.8 9 (This part of the study has not yet been completed.)
Kallikrein activity,'6 kininase I and II activities,'7 and creatinine, total nitrogen, proteins, sodium, potassium, and calcium were measured in the 24 urine samples by standard techniques.
The statistical analysis of the data was made by the Dunnet t test for multiple comparison'8 and was considered to be significant when p values were < 0-05.
Results
Systolic and diastolic blood pressure, but not cardiac inotropism (dP/dt) and heart rate, were augmented in all the rats exposed to vanadium. These changes were not dosedependent (table 1 Histopathological examination by light microscopy did not show alterations in the brain, liver, lungs, heart, or blood vessels of treated rats. In these animals, glomeruli and renal vessels were also normal although in rats exposed to 40 ppm of vanadium the lumen of proximal tubules was narrowed and contained amorphous material. Hydropic degeneration was also seen in some proximal, distal, and straight tubules. Such abnormalities were less evident in the rats treated with 10 ppm of vanadium and absent in those treated with 1 ppm of vanadium. In the control rats Na+, K+-ATPase activity was higher in distal tubules in the cortex and in straight tubules in the medulla (figure). In rats exposed to 40 ppm of vanadium, Na+ , K+-ATPase activity was reduced; the decrease in this enzymatic activity was more evident in the nephrons with morphological alterations.
Plasma renin activity was augmented to similar values in the rats exposed to 10 or 40 ppm of vanadium, whereas it remained unchanged in the rats given 1 yug/ml of vanadium (table 2) .
Kallikrein activity was increased in the urine of rats treated with 10 or 40 jug/ml of vanadium and decreased after treatment with 1 /ug/ml (table 3) .
Urinary kininase I and II activities were increased in the rats exposed to 40 and 10 ppm of vanadium and unchanged in those exposed to 1 ppm of vanadium (table 3) .
Vanadate treatment did not modify the urinary excretion of creatinine, total nitrogen, protein, and sodium. Urinary potassium decreased with dose, whereas calcium was reduced in the lowest exposure group (table 4) .
Discussion
The results of this study show that chronic exposure of rats to different doses of vanadate, lower than those given in previous experiments,7 is able to induce arterial hypertension by increasing total peripheral resistance, as indicated by the lack of changes in cardiac inotropism and heart rate. Increased heart rate was found only in rats treated with 100 ppm of vanadium where the central and peripheral sympathetic hyperactivity was counteracted by the reduction of both baroreflex activity and vagal tone. 8 9 Male Sprague-Dawley rats exposed to vanadate according to the protocol of this investigation showed (after intravenous injection of substances and physiological agonists) increased cardiovascular responses to the specific stimulation of adrenergic receptors.'920
These rats also showed increased responses to bradykinin (injected intravenously), dependent on activation of both bradykinin, (vascular) and bradykinin2 (cardiac) receptors, as well as reduced baroafferent nerve activity and augmented plasma concentrations of catecholamines. 20 The contractile processes in cardiac and vascular myocells are dependent, with some differences, on the availability of free calcium and are mainly regulated by the activity of both receptor operated slow calcium channels and cyclic nucleotide pathways.2' This study suggests that chronic exposure to vanadate also affects the contractility of myocells by acting on renin-angiotensin-aldosterone and kallikrein-kinin systems. This is confirmed by the finding that exposure to vanadate not only acts on the urinary excretion of kallikrein and kinins but increases the cardiovascular responses to bradykinin.8 9 19 20 Vanadium inhibited synthesis or release of renin in both conscious dogs receiving vanadate by an intravenous route'0 and in renal cortical slices incubated with vanadate.22 This effect on renin was only partly mediated through the inhibition of Na+, K+-ATPase, 
